Predictions
Biogen Inc.
Start price
Target price
Perf. (%)
€194.35
27.04.24
27.04.24
€200.00
27.04.25
27.04.25
5.58%
12.05.24
12.05.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Thermo Fisher Scientific Inc.
Start price
Target price
Perf. (%)
€531.40
27.03.24
27.03.24
-
27.04.24
27.04.24
1.30%
28.04.24
28.04.24
IQVIA Holdings Inc.
Start price
Target price
Perf. (%)
€221.50
14.02.24
14.02.24
€240.00
15.05.24
15.05.24
-5.51%
06.05.24
06.05.24
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€41.78
02.02.24
02.02.24
-
-
03.02.24
03.02.24
Could be worthwhile Investment >10% per year
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€451.50
26.01.24
26.01.24
-
26.02.24
26.02.24
7.31%
27.02.24
27.02.24
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€47.60
05.01.24
05.01.24
-
05.01.25
05.01.25
0.63%
05.03.24
05.03.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€75.96
02.01.24
02.01.24
€80.00
02.02.24
02.02.24
-6.29%
22.01.24
22.01.24
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€471.50
25.12.23
25.12.23
-
25.12.24
25.12.24
6.04%
05.01.24
05.01.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€529.00
18.12.23
18.12.23
€558.00
18.12.24
18.12.24
6.62%
06.01.24
06.01.24
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€526.00
14.12.23
14.12.23
€558.00
14.12.24
14.12.24
0.57%
18.12.23
18.12.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€69.02
13.12.23
13.12.23
€75.00
04.04.24
04.04.24
25.47%
25.03.24
25.03.24
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€357.30
13.12.23
13.12.23
€396.00
04.07.24
04.07.24
10.15%
24.01.24
24.01.24